By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accipiter Life Sciences Fund last week informed Orchid Cellmark that it will nominate three individuals to serve on the DNA testing company's board of directors — a move that would effectively replace the three Class I directors of the current board, according to a filing with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.